# Effects of postoperative complications in oesophageal cancer on survival, hospital outcomes, and long-term quality of life: retrospective cohort study

**Authors:** Nerma Crnovrsanin, Stefan Giring, Antonia Oppel, Ingmar F Rompen, Sabine Schiefer, Nicolas Jorek, Thomas Schmidt, Beat P Müller-Stich, Leila Sisic, Henrik Nienhüser

PMC · DOI: 10.1093/bjsopen/zraf083 · BJS Open · 2025-08-02

## TL;DR

This study shows that preventing postoperative complications like pneumonia and anastomotic leaks can significantly improve survival and reduce hospital stays in oesophageal cancer patients.

## Contribution

The study introduces population-attributable fractions to quantify how specific postoperative complications impact survival and hospital outcomes in oesophageal cancer patients.

## Key findings

- Pneumonia had the highest adjusted PAF for overall survival (8.3% at 2 years).
- Anastomotic leak most significantly contributed to reoperations and prolonged hospital stays.

## Abstract

Postoperative complications pose a major challenge in oesophageal surgery, affecting survival, recovery, and healthcare resource utilization. The aim of this study was to quantify the proportional contribution of specific complications to survival and adverse outcomes and to evaluate their effects on long-term quality of life (QoL) in patients with oesophageal and gastro-oesophageal junction cancer.

This retrospective cohort study included patients with oesophageal or gastro-oesophageal junction cancer who underwent surgery with curative intent between January 2010 and July 2022. Postoperative complications were categorized following Esophageal Complications Consensus Group guidelines. Population-attributable fractions (PAFs) were calculated to estimate the proportion of adverse outcomes and survival effects theoretically preventable if specific complications were avoided.

In 632 patients who underwent surgery, the most frequently observed complications were pulmonary (31%), infectious (29%), and gastrointestinal (24%). Pneumonia had the highest adjusted PAF for overall survival (8.3% after 2 years; 95% confidence interval (c.i.) 1.8 to 14.7), suggesting that preventing pneumonia could substantially reduce mortality. Anastomotic leak had the highest PAF for recurrence-free survival (6.6%; 95% c.i. 1.8 to 11.5) and was the complication most significantly contributing to reoperations (PAF 39.8%; 95% c.i. 22.2 to 52.1) and prolonged hospital stays (PAF 56.9%; 95% c.i. 46.8 to 66.2). Respiratory failure had the largest effect on 90-day mortality (PAF 53.5%; 95% c.i. 30.9 to 73.9). In contrast, no significant effect of complications on long-term QoL was observed.

This study underscores the critical importance of targeted strategies to prevent postoperative complications, particularly pneumonia and anastomotic leakage, which contribute significantly to adverse outcomes such as reduced survival and prolonged hospital stays. Effective complication management may enhance oncological outcomes and optimize healthcare resource utilization.

This study evaluated the impact of postoperative complications on long-term survival and recurrence in 632 patients with oesophageal cancer using population-attributable fractions (PAFs) and multivariable Cox regression. Pneumonia had the highest adjusted PAF for overall survival (8.3% at 2 years), whereas anastomotic leak significantly affected recurrence-free survival (PAF 6.6%) and hospital outcomes. These findings emphasize the proportional contribution of complications to survival and the need for targeted perioperative strategies.

## Linked entities

- **Diseases:** pneumonia (MONDO:0005249), respiratory failure (MONDO:0021113)

## Full-text entities

- **Diseases:** Anastomotic leak (MESH:D057868), Postoperative complications (MESH:D011183), oesophageal and gastro-oesophageal junction cancer (MESH:D005764), diabetes (MESH:D003920), gastrointestinal (MESH:D005767), Pulmonary complications (MESH:D008171), myocardial infarction (MESH:D009203), SCC (MESH:D002294), Respiratory failure (MESH:D012131), Cancer (MESH:D009369), chyle leak (MESH:D019559), adenocarcinoma (MESH:D000230), carotid stenosis (MESH:D016893), insomnia (MESH:D007319), renal insufficiency (MESH:D051437), chronic obstructive pulmonary disease (MESH:D029424), infectious (MESH:D003141), ASA (MESH:C000719191), coronary heart disease (MESH:D003327), dysrhythmia (MESH:D001145), cardiac complications (MESH:D006331), stroke (MESH:D020521), necrosis (MESH:D009336), lung emphysema (MESH:D008478), metastases (MESH:D009362), Complications (MESH:D008107), liver cirrhosis (MESH:D008103), cardiac insufficiency (MESH:D000309), upper gastrointestinal cancers (MESH:D005770), PAF (MESH:D020969), death (MESH:D003643), sepsis (MESH:D018805), Esophageal Complications (MESH:D004935), chronic pancreatitis (MESH:D050500), Pneumonia (MESH:D011014), postoperative (MESH:D019106)
- **Chemicals:** FLOT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12317276/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12317276/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12317276/full.md

---
Source: https://tomesphere.com/paper/PMC12317276